Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127804431 | 12780443 | 1 | I | 20160916 | 20160926 | 20160926 | EXP | NZ-PFIZER INC-2016438627 | PFIZER | 56.00 | YR | M | Y | 0.00000 | 20160926 | MD | NZ | NZ |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127804431 | 12780443 | 1 | PS | SUNITINIB MALATE. | SUNITINIB MALATE | 1 | 50 MG/DAY (4/2 SCHEDULE) | U | 21938 | 50 | MG | ||||||||
127804431 | 12780443 | 2 | SS | SUNITINIB MALATE. | SUNITINIB MALATE | 1 | 2/1 SCHEDULE | U | 21938 | ||||||||||
127804431 | 12780443 | 3 | SS | SUNITINIB MALATE. | SUNITINIB MALATE | 1 | 50 MG, DAILY, CONTINIOUS | U | 21938 | 50 | MG | ||||||||
127804431 | 12780443 | 4 | SS | SUNITINIB MALATE. | SUNITINIB MALATE | 1 | 62.5 MG, DAILY, CONTINUOUS | U | 21938 | 62.5 | MG | ||||||||
127804431 | 12780443 | 5 | SS | SUNITINIB MALATE. | SUNITINIB MALATE | 1 | 75 MG, ONCE DAILY | U | 21938 | 75 | MG | ||||||||
127804431 | 12780443 | 6 | C | CLEXANE | ENOXAPARIN SODIUM | 1 | 100 MG, 1X/DAY | 0 | 100 | MG | QD | ||||||||
127804431 | 12780443 | 7 | C | ZOLEDRONIC ACID | ZOLEDRONIC ACID | 1 | 4 MG, EVERY 3 WEEKS | 0 | 4 | MG | Q3W |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127804431 | 12780443 | 1 | Renal cell carcinoma |
127804431 | 12780443 | 6 | Vena cava thrombosis |
127804431 | 12780443 | 7 | Hypercalcaemia |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127804431 | 12780443 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127804431 | 12780443 | Disease progression | |
127804431 | 12780443 | Lymphoedema | |
127804431 | 12780443 | Renal cell carcinoma | |
127804431 | 12780443 | Ulcer |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127804431 | 12780443 | 1 | 20111019 | 0 | ||
127804431 | 12780443 | 2 | 20111223 | 0 | ||
127804431 | 12780443 | 3 | 201202 | 0 | ||
127804431 | 12780443 | 4 | 20120622 | 0 | ||
127804431 | 12780443 | 5 | 20120921 | 0 |